Pfizer
US CDC will not publish report showing COVID vaccine effectiveness
"Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication," said HHS spokesperson Andrew Nixon.
'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion
Grapevine, November 30, 2025: Mamdani complexities
MBS’s first Washington trip since 2018 brings new investments
European Medicines Agency recommends Novavax add warning to their COVID-19 vaccine
The European Medicines Agency (EMA) is recommending that Novavax should start putting a warning label on their COVID-19 vaccines due to a small number of reported cases of heart inflammation.
AION, aMoon up for top scientific innovation award
AION Labs brings together some of the biggest names in pharma, including AstraZeneca, Merck and Pfizer, and aMoon is Israel’s largest health-tech fund.
Pfizer profit beats estimates on higher demand for COVID products
Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1b, while vaccine sales surged 20%, helping the drugmaker reaffirm the combined 2022 revenue forecast of $54b.
COVID-19 booster shots are crucial, according to a Yale study
New study by Yale, UNC, shows that peak antibody levels achieved by getting vaccinated with an mRNA vaccine exceed those gained from natural infection.
Pfizer CEO Dr. Albert Bourla - Jewish COVID-19 hero
Genesis Prize Deputy CEO Sana Britavsky: “Albert himself is a humble man, but also a remarkable Jewish phenomenon.”
US FDA allows pharmacists to prescribe Pfizer's COVID pill
Use of the pill, authorized to treat newly infected, at-risk people to prevent severe illness, has jumped in recent weeks as infections rise.
COVID-19 hero: Pfizer CEO Albert Bourla reflects on the past, future
Bourla revealed that he would donate the $1 million award to building a Holocaust museum in his hometown in an interview for The Jerusalem Post.
Pfizer CEO Albert Bourla receives honorary doctorate from Technion
Bourla was recognized for his exceptional leadership in developing the first safe and effective COVID-19 vaccine, which remains the gold standard for vaccines against the novel coronavirus.
President of Israel Presents the 2022 'Jewish Nobel Prize' to Pfizer CEO Albert Bourla in Jerusalem
Bourla donates $1 million award towards construction of Holocaust Museum of Greece in Thessaloniki to commemorate Greek-Jewish communities wiped out by the Nazis.
EU chief can't find texts with Pfizer chief on COVID-19 vaccine deal
European Commission president Ursula von der Leyen exchanged texts with Pfizer chief Albert Bourla for a month when they were negotiating a massive vaccine contract.